146 related articles for article (PubMed ID: 11604397)
1. DNA converts cellular prion protein into the beta-sheet conformation and inhibits prion peptide aggregation.
Cordeiro Y; Machado F; Juliano L; Juliano MA; Brentani RR; Foguel D; Silva JL
J Biol Chem; 2001 Dec; 276(52):49400-9. PubMed ID: 11604397
[TBL] [Abstract][Full Text] [Related]
2. The H187R mutation of the human prion protein induces conversion of recombinant prion protein to the PrP(Sc)-like form.
Hosszu LL; Tattum MH; Jones S; Trevitt CR; Wells MA; Waltho JP; Collinge J; Jackson GS; Clarke AR
Biochemistry; 2010 Oct; 49(40):8729-38. PubMed ID: 20718410
[TBL] [Abstract][Full Text] [Related]
3. Reversible conversion of monomeric human prion protein between native and fibrilogenic conformations.
Jackson GS; Hosszu LL; Power A; Hill AF; Kenney J; Saibil H; Craven CJ; Waltho JP; Clarke AR; Collinge J
Science; 1999 Mar; 283(5409):1935-7. PubMed ID: 10082469
[TBL] [Abstract][Full Text] [Related]
4. Design of anti- and pro-aggregation variants to assess the effects of methionine oxidation in human prion protein.
Wolschner C; Giese A; Kretzschmar HA; Huber R; Moroder L; Budisa N
Proc Natl Acad Sci U S A; 2009 May; 106(19):7756-61. PubMed ID: 19416900
[TBL] [Abstract][Full Text] [Related]
5. Modulation of proteinase K-resistant prion protein in cells and infectious brain homogenate by redox iron: implications for prion replication and disease pathogenesis.
Basu S; Mohan ML; Luo X; Kundu B; Kong Q; Singh N
Mol Biol Cell; 2007 Sep; 18(9):3302-12. PubMed ID: 17567949
[TBL] [Abstract][Full Text] [Related]
6. Molecular biology and pathology of prion strains in sporadic human prion diseases.
Gambetti P; Cali I; Notari S; Kong Q; Zou WQ; Surewicz WK
Acta Neuropathol; 2011 Jan; 121(1):79-90. PubMed ID: 21058033
[TBL] [Abstract][Full Text] [Related]
7. Aptamers against prion proteins and prions.
Gilch S; Schätzl HM
Cell Mol Life Sci; 2009 Aug; 66(15):2445-55. PubMed ID: 19396399
[TBL] [Abstract][Full Text] [Related]
8. The P's and Q's of cellular PrP-Aβ interactions.
Westaway D; Jhamandas JH
Prion; 2012; 6(4):359-63. PubMed ID: 22874673
[TBL] [Abstract][Full Text] [Related]
9. Conformational properties of beta-PrP.
Hosszu LLP; Trevitt CR; Jones S; Batchelor M; Scott DJ; Jackson GS; Collinge J; Waltho JP; Clarke AR
J Biol Chem; 2009 Aug; 284(33):21981-21990. PubMed ID: 19369250
[TBL] [Abstract][Full Text] [Related]
10. Spontaneous conformational change within the prion protein--implications for disease pathogenesis?
Jackson GS
Bioessays; 2001 Sep; 23(9):772-4. PubMed ID: 11536289
[TBL] [Abstract][Full Text] [Related]
11. Charge neutralization of the central lysine cluster in prion protein (PrP) promotes PrP(Sc)-like folding of recombinant PrP amyloids.
Groveman BR; Kraus A; Raymond LD; Dolan MA; Anson KJ; Dorward DW; Caughey B
J Biol Chem; 2015 Jan; 290(2):1119-28. PubMed ID: 25416779
[TBL] [Abstract][Full Text] [Related]
12. Mapping the early steps in the pH-induced conformational conversion of the prion protein.
Alonso DO; DeArmond SJ; Cohen FE; Daggett V
Proc Natl Acad Sci U S A; 2001 Mar; 98(6):2985-9. PubMed ID: 11248018
[TBL] [Abstract][Full Text] [Related]
13. Mapping the antigenicity of copper-treated cellular prion protein with the scrapie isoform.
Wong BS; Li R; Sassoon J; Kang SC; Liu T; Pan T; Greenspan NS; Wisniewski T; Brown DR; Sy MS
Cell Mol Life Sci; 2003 Jun; 60(6):1224-34. PubMed ID: 12861388
[TBL] [Abstract][Full Text] [Related]
14. Chaperone-supervised conversion of prion protein to its protease-resistant form.
DebBurman SK; Raymond GJ; Caughey B; Lindquist S
Proc Natl Acad Sci U S A; 1997 Dec; 94(25):13938-43. PubMed ID: 9391131
[TBL] [Abstract][Full Text] [Related]
15. Post-conversion sialylation of prions in lymphoid tissues.
Srivastava S; Makarava N; Katorcha E; Savtchenko R; Brossmer R; Baskakov IV
Proc Natl Acad Sci U S A; 2015 Dec; 112(48):E6654-62. PubMed ID: 26627256
[TBL] [Abstract][Full Text] [Related]
16. Immobilized prion protein undergoes spontaneous rearrangement to a conformation having features in common with the infectious form.
Leclerc E; Peretz D; Ball H; Sakurai H; Legname G; Serban A; Prusiner SB; Burton DR; Williamson RA
EMBO J; 2001 Apr; 20(7):1547-54. PubMed ID: 11285219
[TBL] [Abstract][Full Text] [Related]
17. Protein conformation significantly influences immune responses to prion protein.
Khalili-Shirazi A; Quaratino S; Londei M; Summers L; Tayebi M; Clarke AR; Hawke SH; Jackson GS; Collinge J
J Immunol; 2005 Mar; 174(6):3256-63. PubMed ID: 15749856
[TBL] [Abstract][Full Text] [Related]
18. Molecular dynamics simulations capture the misfolding of the bovine prion protein at acidic pH.
Cheng CJ; Daggett V
Biomolecules; 2014 Feb; 4(1):181-201. PubMed ID: 24970211
[TBL] [Abstract][Full Text] [Related]
19. The cellular prion protein (PrP(C)): its physiological function and role in disease.
Westergard L; Christensen HM; Harris DA
Biochim Biophys Acta; 2007 Jun; 1772(6):629-44. PubMed ID: 17451912
[TBL] [Abstract][Full Text] [Related]
20. Isolation of soluble and insoluble PrP oligomers in the normal human brain.
Xiao X; Yuan J; Zou WQ
J Vis Exp; 2012 Oct; (68):. PubMed ID: 23070047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
